Neuropeptides
Volume 44, Issue 5 , Pages 355-361 , October 2010

Distinct distribution of corticotropin releasing factor receptors in human breast cancer

  • A. Kaprara

      Affiliations

    • Anticancer Hospital ‘Theagenio’, Simeonidi 2, 54639, Thessaloniki, Greece
    • Equally contributed to the article.
    • ,
  • K. Pazaitou-Panayiotou

      Affiliations

    • Anticancer Hospital ‘Theagenio’, Simeonidi 2, 54639, Thessaloniki, Greece
    • Equally contributed to the article.
    • ,
  • M.C. Chemonidou

      Affiliations

    • Laboratory of Pharmacology, Dept. of Medicine, Democritus University of Thrace (DUTH), Dragana, Alexandroupolis 68100, Greece
    • ,
  • T.C. Constantinidis

      Affiliations

    • Laboratory of Hygiene, Dept. of Medicine, DUTH, Dragana, Alexandroupolis 68100, Greece
    • ,
  • M. Lambropoulou

      Affiliations

    • Laboratory of Histology-Embryology, Dept. of Medicine, DUTH, Dragana, Alexandroupolis 68100, Greece
    • ,
  • M. Koffa

      Affiliations

    • Laboratory of Cellular and Molecular Biology, Dept. of Molecular Biology and Genetics, DUTH, Dragana, Alexandroupolis 68100, Greece
    • ,
  • A. Kiziridou

      Affiliations

    • Anticancer Hospital ‘Theagenio’, Simeonidi 2, 54639, Thessaloniki, Greece
    • ,
  • S. Kakolyris

      Affiliations

    • Oncology Clinic, Dept. of Medicine, DUTH, Dragana, Alexandroupolis 68100, Greece
    • ,
  • A. Kortsaris

      Affiliations

    • Laboratory of Biochemistry, Dept. of Medicine, DUTH, Dragana, Alexandroupolis 68100, Alexandroupolis, Greece
    • ,
  • E. Chatzaki

      Affiliations

    • Laboratory of Pharmacology, Dept. of Medicine, Democritus University of Thrace (DUTH), Dragana, Alexandroupolis 68100, Greece
    • Corresponding Author InformationCorresponding author. Address: Department of Pharmacology, DUTH, Dragana, Alexandroupolis 68100, Thrace, Greece. Tel./fax: +30 2551030533.

Received 30 April 2010 ,Accepted 17 June 2010.

References 

  1. Androulidaki A, Dermitzaki E, Venihaki M, Karagianni E, Rassouli O, Andreakou E, et al. Corticotropin releasing factor promotes breast cancer cell motility and invasiveness. Mol. Cancer. 2009;8:30
  2. Arbiser JL, Karalis K, Viswanathan A, Koike C, Anand-Apte B, Flynn E, et al. Corticotropin-releasing hormone stimulates angiogenesis and epithelial tumor growth in the skin. J. Invest. Dermatol. 1999;113:838–842
  3. Baigent SM. Peripheral corticotropin-releasing hormone and urocortin in the control of the immune response. Peptides. 2001;22:809–820
  4. Bale TL, Vale WW. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu. Rev. Pharmacol. Toxicol. 2004;44:525–557
  5. Brar BK, Stephanou A, Okosi A, Lawrence KM, Knight RA, Marber MS, et al. CRH-like peptides protect cardiac myocytes from lethal ischaemic injury. Mol. Cell. Endocrinol. 1999;158:55–63
  6. Chatzaki E, Charalampopoulos I, Leontidis C, Mouzas IA, Tzardi M, Tsatsanis C, et al. Urocortin in human gastric mucosa: relationship to inflammatory activity. J. Clin. Endocrinol. Metab. 2003;88:478–483
  7. Chatzaki E, Crowe PD, Wang L, Million M, Tache Y, Grigoriadis DE. CRF receptor type 1 and 2 expression and anatomical distribution in the rat colon. J. Neurochem. 2004;90:309–316
  8. Chatzaki E, Murphy BJ, Wang L, Million M, Ohning GV, Crowe PD, et al. Differential profile of CRF receptor distribution in the rat stomach and duodenum assessed by newly developed CRF receptor antibodies. J. Neurochem. 2004;88:1–11
  9. Chatzaki E, Euthymiadis C, Kyriaki S, Lambropoulou M, Tsaroucha A, Laftsidis P, et al. Urocortin and corticotropin-releasing hormone receptor type 2 expression in the human gallbladder. Neuroendocrinology. 2005;82:177–184
  10. Chatzaki E, Lambropoulou M, Constantinidis TC, Papadopoulos N, Tache Y, Minopoulos G, et al. Corticotropin-releasing factor (CRF) receptor type 2 in the human stomach: protective biological role by inhibition of apoptosis. J. Cell Physiol. 2006;209:905–911
  11. Chen R, Lewis KA, Perrin MH, Vale WW. Expression cloning of a human corticotropin-releasing-factor receptor. Proc. Natl. Acad. Sci. USA. 1993;90:8967–8971
  12. Ciocca DR, Puy LA, Fasoli LC, Tello O, Aznar JC, Gago FE, et al. Corticotropin-releasing hormone, luteinizing hormone-releasing hormone, growth hormone-releasing hormone, and somatostatin-like immunoreactivities in biopsies from breast cancer patients. Breast Cancer Res. Treat. 1990;15:175–184
  13. Florio P, De Falco G, Leucci E, Torricelli M, Torres PB, Toti P, et al. Urocortin expression is downregulated in human endometrial carcinoma. J. Endocrinol. 2006;190:99–105
  14. Graziani G, Tentori L, Muzi A, Vergati M, Tringali G, Pozzoli G, et al. Evidence that corticotropin-releasing hormone inhibits cell growth of human breast cancer cells via the activation of CRH-R1 receptor subtype. Mol. Cell Endocrinol. 2007;264:44–49
  15. Graziani G, Tentori L, Portarena I, Barbarino M, Tringali G, Pozzoli G, et al. CRH inhibits cell growth of human endometrial adenocarcinoma cells via CRH-receptor 1-mediated activation of cAMP-PKA pathway. Endocrinology. 2002;143:807–813
  16. Grino M, Chrousos GP, Margioris AN. The corticotropin releasing hormone gene is expressed in human placenta. Biochem. Biophys. Res. Commun. 1987;148:1208–1214
  17. Imperatore A, Florio P, Torres PB, Torricelli M, Galleri L, Toti P, et al. Urocortin 2 and urocortin 3 are expressed by the human placenta, deciduas, and fetal membranes. Am. J. Obstet. Gynecol. 2006;195:288–295
  18. Kaprara, A., Pazaitou-Panayiotou, K., Kortsaris, A., Chatzaki, E., 2010. The corticotropin releasing factor system in cancer: expression and pathophysiological implications. Cell Mol. Life Sci.
  19. Kostich WA, Chen A, Sperle K, Largent BL. Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2gamma receptor. Mol. Endocrinol. 1998;12:1077–1085
  20. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–408
  21. Lovenberg TW, Liaw CW, Grigoriadis DE, Clevenger W, Chalmers DT, De Souza EB, et al. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain [published erratum appears in Proc. Natl. Acad. Sci. USA 1995 Jun 6, 92 (12), 5759]. Proc. Natl. Acad. Sci. USA. 1995;92:836–840
  22. Makrigiannakis A, Margioris AN, Le Goascogne C, Zoumakis E, Nikas G, Stournaras C, et al. Corticotropin-releasing hormone (CRH) is expressed at the implantation sites of early pregnant rat uterus. Life Sci. 1995;57:1869–1875
  23. Miceli F, Ranelletti FO, Martinelli E, Petrillo M, Scambia G, Navarra P, et al. Expression and subcellular localization of CRH and its receptors in human endometrial cancer. Mol. Cell Endocrinol. 2009;305:6–11
  24. Minas V, Rolaki A, Kalantaridou SN, Sidiropoulos J, Mitrou S, Petsas G, et al. Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation. Br. J. Cancer. 2007;97:637–645
  25. Muramatsu Y, Fukushima K, Iino K, Totsune K, Takahashi K, Suzuki T, et al. Urocortin and corticotropin-releasing factor receptor expression in the human colonic mucosa. Peptides. 2000;21:1799–1809
  26. Nagashima H, Asakura M, Hishinuma T, Tanaka D, Fujii S. Reduction and sensitization of CRH neuron in rat hypothalamic and extrahypothalamic regions after chronic variable stress. Nihon Shinkei Seishin Yakurigaku Zasshi. 2003;23:21–28
  27. Reubi JC, Waser B, Vale W, Rivier J. Expression of CRF1 and CRF2 receptors in human cancers. J. Clin. Endocrinol. Metab. 2003;88:3312–3320
  28. Simopoulos C, Christodoulou E, Lambropoulou M, Tsaroucha AK, Kakolyris S, Polychronidis A, et al. Neuropeptide urocortin 1 and its receptors are expressed in the human liver. Neuroendocrinology. 2008;
  29. Simopoulos C, Christodoulou E, Lambropoulou M, Tsaroucha AK, Kakolyris S, Polychronidis A, et al. Neuropeptide urocortin 1 and its receptors are expressed in the human liver. Neuroendocrinology. 2009;89:315–326
  30. Tjuvajev J, Kolesnikov Y, Joshi R, Sherinski J, Koutcher L, Zhou Y, et al. Anti-neoplastic properties of human corticotropin releasing factor: involvement of the nitric oxide pathway. In Vivo. 1998;12:1–10
  31. Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science. 1981;213:1394–1397
  32. Zoumakis E, Chatzaki E, Charalampopoulos I, Margioris AN, Angelakis E, Koumantakis E, et al. Cycle and age-related changes in corticotropin-releasing hormone levels in human endometrium and ovaries. Gynecol. Endocrinol. 2001;15:98–102

☆ Sources of Support: This work was supported by the Annual Funding of the Faculty of Medicine by the Ministry of Education.

PII: S0143-4179(10)00069-7

doi: 10.1016/j.npep.2010.06.005

Neuropeptides
Volume 44, Issue 5 , Pages 355-361 , October 2010

Article Tools

* Image Usage & Resolution